Smart scans aim to zap kidney cancer spots with precision
NCT ID NCT07540260
First seen Apr 30, 2026 · Last updated May 13, 2026 · Updated 5 times
Summary
This study tests whether combining a special PET/CT scan (CAIX-targeted) with standard imaging can better find and treat cancer spots in people with advanced kidney cancer. About 70 adults with recurrent or metastatic clear cell renal cell carcinoma will receive standard drug therapy plus targeted radiation to visible tumors. The goal is to see if this approach delays cancer progression and controls treated lesions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RADIATION THERAPY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking University First Hospital
RECRUITINGBeijing, Beijing Municipality, 100034, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.